Digital Look

Welcome to Digital Look++,
you are not logged in

Creo Medical Group (CREO)

Health Care

10.13p

Trade now with Barclays Stockbrokers

Select chart: EPS | Dividend | Revenue

Period Ending	Period	Revenue (£m)	Pre-tax (£m)	EPS	Dividend
30-Jun-24	Interim	15.20	(13.80)	(0.03)p	n/a

Year Ending	Revenue (£m)	Pre-tax (£m)	EPS	P/E	PEG	EPS Grth.	Div	Yield
31-Dec-19	0.01	(18.62)	(12.54)p	n/a	n/a	n/a	n/a	0.0%
31-Dec-20	9.43	(23.46)	(12.54)p	n/a	n/a	n/a	n/a	0.0%
31-Dec-21	25.16	(30.34)	(14.48)p	n/a	n/a	n/a	n/a	0.0%
31-Dec-22	27.20	(30.90)	(14.48)p	n/a	n/a	n/a	n/a	0.0%
31-Dec-23	30.80	(24.50)	(7.00)p	n/a	n/a	n/a	n/a	0.0%

a. Based on UK GAAP presentation of accounts - includes discontinued activities

Year Ending	Revenue (£m)	Pre-tax (£m)	EPS	P/E	PEG	EPS Grth.	Div	Yield
31-Dec-24	31.23	(22.89)	(5.96)p	n/a	n/a	n/a	n/a	0.0%
31-Dec-25	27.47	(9.10)	(3.94)p	n/a	n/a	n/a	n/a	0.0%
31-Dec-26	36.58	(12.03)	(1.88)p	n/a	n/a	n/a	n/a	0.0%

	5 Yr High	5 Yr Low	5 Yr Avg	Curr / Avg
Latest	n/a	n/a	n/a	0

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 3: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 4: In the case of dual listed securities, broker recommendations and forecasts relate to the primary listing.

Note 5: Forecast figures based on normalised accounts.

Find out about IFRS and how this affects the financial infomation for all UK companies.